Regulatory Approval

4 February 08


                           ECO Animal Health Group plc
                             (formerly Lawrence plc)

                     ECO ENTERS THE COMPANION ANIMAL SECTOR

Eco Animal Health Group plc is pleased to announce that its subsidiary Eco
Animal Health Limited (Eco) has been granted a marketing authorisation in Japan
for Ecoheart Chewable Tablets for dogs.

Ecoheart Chewable Tablets is the first companion animal product for which Eco
has received a marketing authorisation and the product's launch in early
February will mark Eco's entry into the important companion animal sector.

Ecoheart Chewable Tablets prevent heartworm disease and are also effective in
the treatment and control of roundworms and hookworms in dogs. Canine heartworm
is potentially fatal and requires a monthly preventative treatment. The canine
heartworm prevention market is one of the three key sectors in the companion
animal market in Japan and is estimated to be worth in the region of US $20
million at manufacturer level.

Contacts:
ECO Animal Health Group plc             Marc Loomes    020 8447 8899

Spiro Financial      Anthony Spiro      020 8336 6196

Cenkos Securities plc                   Stephen Keys   020 7397 8926
(Nominated Adviser)

ECO  Animal  Health Group plc is a leader in the development,  registration  and
marketing of pharmaceutical products for animals. Our products for these  global
growth markets promote well being . Our financial goals are achieved through the
careful  and  responsible  application of science  to  generate  value  for  our
shareholders.